<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo>, an independent risk-factor for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, precedes type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and is associated with ectopic <z:hpo ids='HP_0009058'>lipid accumulation in skeletal muscle</z:hpo> and liver </plain></SENT>
<SENT sid="1" pm="."><plain>Recent evidence indicates that cardiac <z:hpo ids='HP_0001397'>steatosis</z:hpo> plays a central role in the development of diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, it is not known whether <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> as such in the absence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with heart <z:hpo ids='HP_0001397'>steatosis</z:hpo> and/or impaired function </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore assessed <z:hpo ids='HP_0006693'>myocardial steatosis</z:hpo> and myocardial function in a sample of women with <z:mpath ids='MPATH_458'>normal</z:mpath> insulin sensitivity, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Magnetic resonance imaging and localised spectroscopy were used to measure left ventricular dynamic variables and myocardial <z:chebi fb="23" ids="18059">lipid</z:chebi> accumulation in interventricular septum of non-diabetic, age- and BMI-matched insulin-sensitive (n = 11, 47 ± 6 years, BMI 25 ± 2 kg/m(2); clamp-like index [CLIX] = 9.7 ± 0.7) and insulin-resistant (n = 10, 48 ± 5 years, 27 ± 4 kg/m(2); CLIX = 4.5 ± 0.4) women with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance as well as of women with IGT (n = 6, 45 ± 5 years, 28 ± 6 kg/m(2); CLIX = 3.6 ± 1.1) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 7, 52 ± 10 years, 27 ± 3 kg/m(2)) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Myocardial <z:chebi fb="23" ids="18059">lipid</z:chebi> content was increased in type 2 diabetic women only (insulin-sensitive 0.4 ± 0.2% [means ± SD]; insulin-resistant 0.4 ± 0.1%; IGT 0.5 ± 0.2%; type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> 0.7 ± 0.3%; p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>In insulin-resistant and type 2 diabetic women, <z:hpo ids='HP_0001297'>stroke</z:hpo> volume was lower (-15% and -27%, respectively, vs insulin-sensitive) and heart rate was higher (11% and 14%, respectively, vs insulin-sensitive, p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>No other differences in systolic and diastolic function were observed between study groups </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: In contrast to liver and skeletal muscle, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> as such is not associated with increased myocardial <z:chebi fb="23" ids="18059">lipid</z:chebi> accumulation </plain></SENT>
</text></document>